Literature DB >> 11959589

In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum.

S Gupta1, M M Thapar, W H Wernsdorfer, A Björkman.   

Abstract

The interactions of artemisinin with atovaquone, quinine, and mefloquine were investigated in three Plasmodium falciparum strains (strains F-32, FCR-3, and K-1) by an in vitro culture assay. The parasites were cultured for 48 h in the presence of different concentrations and proportions of two drugs at a time in a checkerboard design. The response parameters were determined, and the sums of the fractional inhibitory concentrations (sigmaFICs) of the drug combinations were calculated for different degrees of inhibition (50% effective concentration [EC50], EC90, and EC99). Within therapeutically relevant molar ratios (19 to 200), the combination of quinine and artemisinin showed mean sigmaFICs of 1.71 at the EC50, 0.36 at the EC90, and 0.13 at the EC99, indicating increasing synergism. Within the range of molar ratios of 4.3 to 50, the combination of mefloquine and artemisinin yielded mean sigmaFCIs of 0.93, 0.44, and 0.31 at the EC50, EC90, and EC99, respectively, indicating synergism. The atovaquone combination showed additive activity to synergism at atovaquone/artemisinin proportions considered relevant to the in vivo situation, i.e., between 4.3 and 200, with the mean sigmaFICs decreasing from 1.34 at the EC50 to 0.85 and 0.23 at the EC90 and EC99, respectively. Interstrain differences in the degree of drug interaction were seen with the three strains for all combinations. Synergism was most consistent with quinine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959589      PMCID: PMC127123          DOI: 10.1128/AAC.46.5.1510-1515.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Synergism between arteether and mefloquine or quinine in a multidrug-resistant strain of Plasmodium falciparum in vitro.

Authors:  R Ekong; D C Warhurst
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Nov-Dec       Impact factor: 2.184

2.  Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand.

Authors:  S Looareesuwan; C Viravan; H K Webster; D E Kyle; D B Hutchinson; C J Canfield
Journal:  Am J Trop Med Hyg       Date:  1996-01       Impact factor: 2.345

3.  Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites.

Authors:  A F Slater; A Cerami
Journal:  Nature       Date:  1992-01-09       Impact factor: 49.962

4.  A clinical trial of combination of artesunate and mefloquine in the treatment of acute uncomplicated falciparum malaria: a short and practical regimen.

Authors:  P Wilairatana; S Krudsood; W Chokejindachai; V Bussaratid; U Silachamroon; P Viriyavejakul; C Hendriksen; M W Scheiwe; S Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  1998-12       Impact factor: 0.267

Review 5.  Qinghaosu.

Authors:  T T Hien; N J White
Journal:  Lancet       Date:  1993-03-06       Impact factor: 79.321

6.  A method for testing for synergy with any number of agents.

Authors:  M C Berenbaum
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

7.  In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand.

Authors:  C Wongsrichanalai; T Wimonwattrawatee; P Sookto; A Laoboonchai; D G Heppner; D E Kyle; W H Wernsdorfer
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

Review 8.  New antimalarials. A risk-benefit analysis.

Authors:  F Nosten; R N Price
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 9.  Research on new antimalarial drugs and the use of drugs in combination at the Bangkok Hospital for Tropical Diseases.

Authors:  S Looareesuwan; P Wilairatana; W Chokejindachai; P Viriyavejakul; S Krudsood; P Singhasivanon
Journal:  Southeast Asian J Trop Med Public Health       Date:  1998-06       Impact factor: 0.267

10.  The chemotherapy of rodent malaria, XXXIX. Ultrastructural changes following treatment with artemisinine of Plasmodium berghei infection in mice, with observations of the localization of [3H]-dihydroartemisinine in P. falciparum in vitro.

Authors:  D S Ellis; Z L Li; H M Gu; W Peters; B L Robinson; G Tovey; D C Warhurst
Journal:  Ann Trop Med Parasitol       Date:  1985-08
View more
  15 in total

1.  Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.

Authors:  Quinton L Fivelman; Ipemida S Adagu; David C Warhurst
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.

Authors:  Karin Seifert; Simon L Croft
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  HIV protease inhibitors, indinavir or nelfinavir, augment antimalarial action of artemisinin in vitro.

Authors:  Lokesh C Mishra; Amit Bhattacharya; Manish Sharma; Virendra K Bhasin
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

4.  Evaluation of the physicochemical equivalence of three brands of commercially available quinine sulphate tablets from South Western part of Nigeria.

Authors:  Ai Adegbite; O M Adegbolagun
Journal:  Afr Health Sci       Date:  2011-06       Impact factor: 0.927

5.  Suitability of methods for Plasmodium falciparum cultivation in atmospheric air.

Authors:  Marcell Crispim; Ignasi Bofill Verdaguer; Sofia Ferreira Silva; Alejandro Miguel Katzin
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-07-18       Impact factor: 2.747

6.  Transport and pharmacodynamics of albitiazolium, an antimalarial drug candidate.

Authors:  S Wein; M Maynadier; Y Bordat; J Perez; S Maheshwari; P Bette-Bobillo; C Tran Van Ba; D Penarete-Vargas; L Fraisse; R Cerdan; H Vial
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

7.  In vitro and in vivo assessment of the anti-malarial activity of Caesalpinia pluviosa.

Authors:  Ana Carolina A V Kayano; Stefanie C P Lopes; Fernanda G Bueno; Elaine C Cabral; Wanessa C Souza-Neiras; Lucy M Yamauchi; Mary A Foglio; Marcos N Eberlin; João Carlos P Mello; Fabio T M Costa
Journal:  Malar J       Date:  2011-05-02       Impact factor: 2.979

8.  Anti-malarial activities of Andrographis paniculata and Hedyotis corymbosa extracts and their combination with curcumin.

Authors:  Kirti Mishra; Aditya P Dash; Bijay K Swain; Nrisingha Dey
Journal:  Malar J       Date:  2009-02-12       Impact factor: 2.979

9.  Oleic acid biosynthesis in Plasmodium falciparum: characterization of the stearoyl-CoA desaturase and investigation as a potential therapeutic target.

Authors:  Paul Gratraud; Enlli Huws; Brie Falkard; Sophie Adjalley; David A Fidock; Laurence Berry; William R Jacobs; Mark S Baird; Henri Vial; Laurent Kremer
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

10.  Effect of ketoconazole, a cytochrome P450 inhibitor, on the efficacy of quinine and halofantrine against Schistosoma mansoni in mice.

Authors:  Sayed Hassan Seif El-Din; Abdel-Nasser Abdel-Aal Sabra; Olfat Ali Hammam; Naglaa Mohamed El-Lakkany
Journal:  Korean J Parasitol       Date:  2013-04-25       Impact factor: 1.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.